In the final weeks of 2018 (and the final weeks of a GOP-controlled House of Representatives), there are a number of potential legislative catalysts for… Read More »Tis The Season For Potential Health Care Catalysts
The research team at Bank of America Merrill Lynch sees big upside potential for Big Pharma in the remaining months of 2018. Here are some… Read More »Big Upside Potential In Big Pharma
With healthcare ETFs displaying positive momentum (and a plethora of reasons to believe that this momentum will continue), this triple-leveraged healthcare ETF could be an… Read More »A Triple Dose Of Healthcare Momentum
This under-the-radar cannabis company is taking a different approach from most – choosing to be the big fish in small ponds. Here’s why its strategy… Read More »An “Unassuming” Cannabis Company With A “Big Fish” Strategy
Among small-cap stocks – which have been robustly outperforming their large-cap counterparts this year – healthcare small-caps have been the most impressive performers. Which healthcare… Read More »Bargain Hunting In Declining Health
As the second-quarter earnings season gets underway, these three healthcare stocks – including a biotech that now has a near monopoly on the cystic fibrosis… Read More »Tip Top Healthcare Bets From Top Analysts
These two biotech companies are big established players rather than exciting start-ups, which may help explain why they find themselves underappreciated by investors right now.… Read More »Reconsider Bypassing These Biotechs
This women-focused medical device stock – the author’s favorite speculative stock for 2018 – has had an impressive run so far this year. Here are… Read More »Healthy Speculation
The U.S. dominates the medical technology market – and with the infamous Medical Device tax suspended (again) for two years, the medical device industry is… Read More »Promising Picks In MedTech